Page last updated: 2024-08-24

fadrozole and Prostatic Neoplasms

fadrozole has been researched along with Prostatic Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Engel, M; Hartmann, RW; Hu, Q; Pinto-Bazurco Mendieta, MA	1
Nicholls, PJ; Shaw, MA; Smith, HJ	1

Reviews

1 review(s) available for fadrozole and Prostatic Neoplasms

Article	Year
Aminoglutethimide and ketoconazole: historical perspectives and future prospects. Journal of steroid biochemistry, 1988, Volume: 31, Issue:1 Topics: Adrenal Gland Neoplasms; Aminoglutethimide; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Imidazoles; Ketoconazole; Male; Nitriles; Prostatic Neoplasms	1988

Other Studies

1 other study(ies) available for fadrozole and Prostatic Neoplasms

Article	Year
Highly potent and selective nonsteroidal dual inhibitors of CYP17/CYP11B2 for the treatment of prostate cancer to reduce risks of cardiovascular diseases. Journal of medicinal chemistry, 2013, Aug-08, Volume: 56, Issue:15 Topics: Antineoplastic Agents; Cardiovascular Diseases; Cell Line; Cytochrome P-450 CYP11B2; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Humans; Male; Models, Molecular; Naphthalenes; Prostatic Neoplasms; Pyridines; Steroid 11-beta-Hydroxylase; Steroid 17-alpha-Hydroxylase	2013

Article

Year

Highly potent and selective nonsteroidal dual inhibitors of CYP17/CYP11B2 for the treatment of prostate cancer to reduce risks of cardiovascular diseases.

Journal of medicinal chemistry, 2013, Aug-08, Volume: 56, Issue:15

Topics: Antineoplastic Agents; Cardiovascular Diseases; Cell Line; Cytochrome P-450 CYP11B2; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Humans; Male; Models, Molecular; Naphthalenes; Prostatic Neoplasms; Pyridines; Steroid 11-beta-Hydroxylase; Steroid 17-alpha-Hydroxylase

2013